MO
MotherHorseEyes
Community Contributor
Member since 2024
Views362Total number of views
Followers8Total number of followers
Comments0Total number of comments
No bio added yet
No link added
LENZ Therapeutics - a high risk high reward small cap biotech stock
Hello Simply Wallstreet I have some DD on a small cap company I want to share. Firstly I want you all to be aware of the risks associated with small caps.Read more
362
users have viewed this narrative8users have liked this narrative
1users have commented on this narrative
9users have followed this narrative
MO
US$200
90.7% undervalued intrinsic discount
MotherHorseEyes's Fair Value
Revenue
247.32% p.a.
Profit Margin
15.03%
Future PE
25.02x
Price in 2030
US$277.58